Identifying creative strategies to address degenerative neurological diseases and psychiatric conditions is one of the most significant challenges in the life science industry today. From malignant brain tumors to anxiety and depression, nervous system conditions have proven to be extremely difficult to target with traditional drug therapies. However, a recent […]